Dexcom has discovered that two lots of scrapped Dexcom G7 continuous glucose monitor (CGM) sensors were stolen and are being sold by a third party in the open market.
The issue came to light during an internal quality and accounting review. The affected lot numbers are 1725204004 and 1725069002. Because these sensors were scrapped product and may not have undergone proper sterilization, they carry a risk of skin infection and may fail to provide accurate readings. No severe adverse events have been reported to date.
Dexcom has traced the distribution of the stolen sensors to Pharmasource, LLC, and is currently working with the FDA and relevant authorities to investigate the matter.
Patients who believe they may have an affected sensor are advised to verify their lot number through Dexcom's official website and to stop using any sensor from the affected lots immediately. Pharmacies are also urged to review their current inventory for these lot numbers.
Dexcom has stated it is committed to transparency throughout this process and will continue to cooperate fully with regulators and investigators.
Want more?
For the latest diabetes tech, join our free newsletter.
If you like our content and want more, join Diabetech All Access—unlocking exclusive Live Q&As, giveaways, stories and industry analysis. Your support helps sustain our independent journalism and keeps this platform thriving.
Disclaimer: Diabetech content is not medical advice—it’s for educational purposes only. Always consult with a healthcare team before making changes to your treatment.